Test Price
2,800 AED✅ Home Collection Available
ADAR Gene Dyschromatosis Symmetrica Hereditaria Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The ADAR gene NGS test identifies pathogenic variants associated with Dyschromatosis Symmetrica Hereditaria (DSH), a rare genodermatosis presenting as reticular hyper‑ and hypopigmented macules on the extremities. This advanced genetic test uses Next‑Generation Sequencing to analyze the full coding region and splice sites of the ADAR gene, ensuring high diagnostic yield and detection of deep intronic and copy number variants.
| Feature | Our Test (ADAR NGS) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Methodology | Next‑Generation Sequencing – full coding region & splice sites | Sanger sequencing of selected ADAR exons |
| Diagnostic Yield | >95% for DSH – captures deep intronic and copy number variants | ~80% – limited to point mutations in screened exons |
| Turnaround Time | 3–4 weeks | 4–6 weeks |
| Clinical Applicability | Confirms diagnosis, family screening, and genetic counselling | Limited familial variant tracking only |
Physician Insight & Safety Protocols
“Dyschromatosis Symmetrica Hereditaria is a clinically distinct pigmentary disorder; this genetic test provides molecular confirmation essential for accurate diagnosis and family planning. Results must be correlated with dermatological findings and a thorough family history by a qualified clinician. Please note that the test is not a substitute for comprehensive clinical examination.”
– Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Pre-Test Advisory
Genetic testing for ADAR-related DSH is recommended for individuals with clinical suspicion of dyschromatosis symmetrica hereditaria, particularly when family history or pigmentary patterns are ambiguous. A thorough clinical evaluation by a dermatologist or medical geneticist should precede testing. Do not discontinue any prescribed medications without consulting your physician.
Safety Exclusion & Red Flags
- Exclusion Criteria: Minors (under 18) without legal guardian consent; individuals unable to provide informed consent; emergency‑room acute dermatological conditions unrelated to chronic pigmentation.
- ER Red Flags: Sudden widespread blistering, severe skin pain, or signs of systemic illness (fever, mucosal involvement) – these require immediate emergency evaluation and are not indicative of routine genetic testing.
- If genetic test results provoke severe anxiety or mental distress, contact our telehealth support or your genetic counsellor promptly.
Patient FAQ & Clinical Guidance
1. What is the ADAR gene dyschromatosis symmetrica hereditaria NGS test?
Direct answer: The ADAR gene NGS test detects mutations causing Dyschromatosis Symmetrica Hereditaria, a rare pigmentary genodermatosis characterized by reticular hyper‑ and hypopigmentation on acral skin. It provides molecular confirmation for accurate diagnosis and family planning.
2. How is the test performed and what is the turnaround time?
Direct answer: A single blood sample is collected by our VIP Mobile Phlebotomy team (available daily from 8 AM to 11 PM) using temperature‑controlled cold‑chain logistics. The sample is processed via Next‑Generation Sequencing, with results delivered in 3–4 weeks.
3. Is this test covered by UAE health insurance?
Direct answer: Many UAE insurers cover genetic testing for hereditary skin disorders when medically indicated. We provide direct billing verification via WhatsApp at +971 54 548 8731.
UAE Regulatory & Data Privacy Adherence
This test is conducted in full compliance with UAE data protection and health information regulations:
- Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) – ensuring the confidentiality and security of patient genetic data.
- Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields – governing electronic health records and digital communications.
- Laboratory operations are certified ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139).
- Clinical referrals initiated by Dermatologists, Clinical Geneticists, or Medical Geneticists registered with DHA.
Clinical & Logistical Metadata
| Test Name | ADAR Gene Dyschromatosis Symmetrica Hereditaria Genetic Test (NGS) |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Peripheral whole blood (collected via VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection) |
| Methodology Used | Next‑Generation Sequencing (full coding region & splice sites) |
| ICD-10-CM Code | Q82.8, Z13.79, Z14.8 |
| LOINC Code | 43401-2 |
| DHA Facility License & Laboratory Address Invariants | DHA License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | Corporate Lab: DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians